Generation, evolution, interfering factors, applications, and challenges of patient-derived xenograft models in immunodeficient mice.

Zeng, Mingtang; Ruan, Zijing; Tang, Jiaxi; Liu, Maozhu; Hu, Chengji; Fan, Ping; Dai, Xinhua

Zeng, Mingtang; Ruan, Zijing; Tang, Jiaxi; Liu, Maozhu; Hu, Chengji; Fan, Ping; Dai, Xinhua.

Afiliação

Zeng M; Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, 610041, China.
Ruan Z; Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, 610041, China.
Tang J; Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, 610041, China.
Liu M; Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, 610041, China.
Hu C; Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, 610041, China.
Fan P; Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, 610041, China. m13980602288@163.com.
Dai X; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, 610041, China. daixinhua@scu.edu.cn.

Cancer Cell Int ; 23(1): 120, 2023 Jun 21.

Article em En | MEDLINE | ID: mdl-37344821

Palavras-chave

Cancer research; Humanized mice; Immunodeficiency mice; Immunotherapy; Patient-derived xenograft; Preclinical model

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancer Cell Int Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google